TP53 and malignant colon neoplasm: It was found that MSM treatment (400 and 500 mM) significantly (p < 0.05) increased caspase-3 enzyme activity in HCT-116 p53 +/+ and HCT-116 p53 −/− colon cancer cells (Figure 3A).